글로벌 폴리클로날 항체 시장 – 2029년까지의 산업 동향 및 예측

글로벌 폴리클로날 항체 시장 분석 및 규모

지난 몇 년 동안 제약 및 생명공학 회사에서 엄청난 성장이 있었습니다. 연구 개발 활동의 증가와 다양한 성장 전략에 대한 시장 참여자의 참여는 시장에 큰 성장을 제공했습니다. 결과적으로 이러한 성장 결정 요인은 예상 기간 동안 상당한 성장을 보일 것으로 예상됩니다.

• 글로벌 폴리클로날 항체 시장은 2021년에 9억 9,739만 달러로 평가되었으며, 2029년까지 15억 5,404만 달러에 도달할 것으로 예상되며, 2022-2029년에 5.70%의 CAGR을 기록할 것입니다. "1차 항체"는 더 큰 특이성으로 인해 예측 기간 내에 폴리클로날 항체 시장 에서 가장 큰 제품 유형 세그먼트를 차지하며 , 연구 개발 활동에서 채택이 증가했습니다. Data Bridge Market Research 팀이 큐레이팅한 시장 보고서에는 심층적인 전문가 분석, 환자 역학, 파이프라인 분석, 가격 분석 및 규제 프레임워크가 포함되어 있습니다.

글로벌 폴리클로날 항체 시장 정의

다클론 항체는 항원에 대한 신체의 정상적인 면역 반응을 나타내는 항체 그룹으로 구성됩니다. 선택한 항원으로 동물을 반복적으로 면역화하는 것은 다클론 항체 개발에 필요합니다. 이들은 다양한 B 세포 계통에서 생성된 항체의 혼합물입니다. 이러한 항체는 특정 항원에 반응하고 해당 항원에서 다른 에피토프를 분리하는 면역글로불린 분자의 집합입니다. 항체는 종종 토끼, 쥐 또는 염소와 같은 적절한 포유류에 바이러스를 접종하여 생성됩니다. 더 큰 포유류는 더 많은 양의 혈청을 수집할 수 있기 때문에 종종 선호됩니다. 항원은 포유류에 주입되어 B 세포가 해당 항원에 특이적인 면역글로불린 G(IgG)를 생성하게 합니다.

보고 범위 및 시장 세분화

Polyclonal Antibodies Market Dynamics

This section deals with understanding the market drivers, opportunities, restraints and challenges. All of this is discussed in detail as below:

Drivers

• Growing Prevalence of Diseases

The global polyclonal antibody market is expected to be driven by an increase in the incidence of infectious diseases and a rise in cancer prevalence, especially across the under developing economies.

Furthermore, the expanding healthcare sector, increase in neurobiology and stem cell research, and the availability of technologically advanced products are also expected to fuel market growth. Moreover, the polyclonal antibodies are highly stable, tolerant of pH and buffer changes which also cushions the market’s growth within the forecasted period. The growing demand for therapeutics antibodies is also projected to bolster the market's growth.

Opportunities

• Growing Research and Development

Moreover, the increase in number of research and development activities across the globe by major pharmaceutical and biotechnology companies are estimated to generate lucrative opportunities for the market.

• Surging Growing Techniques

Additionally, to maintain their positions in the highly competitive market, the companies employ a variety of techniques. Industry leaders in the global polyclonal antibody market use a variety of methods, including partnerships, mergers and acquisitions and collaboration which will further offer numerous growth opportunities for the market.

Restraints/Challenges Global Polyclonal Antibodies Market

• Stringent Regulations

Stringent government regulations and less standard validation process of production are expected to obstruct market growth.

• Low Purity and High Cost

Also, the cost of research antibodies is very high. The factors such as  low purity and concentration levels of specific polyclonal antibodies are projected to challenge the polyclonal antibodies market in the forecast period of 2022-2029.

This polyclonal antibodies market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the polyclonal antibodies market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Post Covid-19 Impact on Polyclonal Antibodies Market

The polyclonal antibodies market was largely impacted by the outbreak of COVID-19. The coronavirus (COVID-19) epidemic and subsequent lockdowns in several nations throughout the world have had a financial impact on enterprises of all types. The private healthcare sector is one of the areas where the COVID-19 epidemic has had a big impact. The imposition of the lockdown and social distancing restrictions by the government to curb the COVID-19 pandemic outbreak, put a financial strain on the healthcare industry in a number of countries. It led to halt of various operations, impeded the production and supply and other negative effects such as stifling business growth, technology event cancellations, suspensions of new developments and has affected the overall production and sales, limiting the industry's expansion. As a result, the worldwide polyclonal antibody market is projected to be constrained by the COVID-19 pandemic throughout the forecast period.

With a gradual decrease in the disease, the restrictions are likely to relax and the various operations will continue, which will help the market witness a slight increment post COVID-19.

Global Polyclonal Antibodies Market Scope

The polyclonal antibodies market is segmented on the basis of product types and application. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.

Product Type

• Primary Antibody
• Secondary Antibody

On the basis of product types, the polyclonal antibodies market is segmented into primary antibody and secondary antibody. The primary antibody segment is registered to hold a dominant share in terms of revenue due to greater specificity which further results in increase adoption in research and development activities.

Application

• Academic Research
• Commercial

On the basis of application, the polyclonal antibodies market is bifurcated into academic research and commercial.

Polyclonal Antibodies Market Regional Analysis/Insights

The polyclonal antibodies market is analyzed and market size insights and trends are provided by country, product types and application as referenced above.

The countries covered in the polyclonal antibodies market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the polyclonal antibodies market because of the continuous ongoing research and development activities along with the high presence of leading players within the region.

Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the increasing prevalence of cancer and other diseases along with the growing demand for therapeutics antibodies within the region.

The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.   

Healthcare Infrastructure growth Installed base and New Technology Penetration

The polyclonal antibodies market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for polyclonal antibodies market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the polyclonal antibodies market. The data is available for historic period 2010-2020.

Competitive Landscape and Polyclonal Antibodies Market Share Analysis

The polyclonal antibodies market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to polyclonal antibodies market.

다클론 항체 시장에서 운영되는 주요 업체 중 일부는 다음과 같습니다.  

• Thermo Fisher Scientific Inc.(미국)
• 머크 KGaA(독일)
• Abcam plc (영국)
• BD(미국)
• Bio-Rad Laboratories Inc.(미국)
• Cell Signaling Technology Inc.(미국)
• F. 호프만-라 로슈 유한회사(스위스)
• 다나허(미국)
• 애질런트 테크놀로지스(미국)
• PerkinElmer Inc.(미국)
• 론자(스위스)
• GenScript(중국)
• BioLegend, Inc. (미국)
• 일루미아 주식회사(미국)
• ImmonoPresice Antibodies Ltd(캐나다)
• 후지레비오(스웨덴)
• Analytik Jena GmbH(독일)
• 오메가 바이오텍 주식회사(미국)
• Dovetail Genomics (미국)
• Atlas Antibodies(스웨덴)

연구 방법론: 글로벌 폴리클로날 항체 시장

데이터 수집 및 기준 연도 분석은 대규모 샘플 크기의 데이터 수집 모듈을 사용하여 수행됩니다. 시장 데이터는 시장 통계 및 일관된 모델을 사용하여 분석 및 추정됩니다. 또한 시장 점유율 분석 및 주요 추세 분석은 시장 보고서의 주요 성공 요인입니다. 자세한 내용은 분석가에게 전화를 요청하거나 문의 사항을 드롭 다운하세요.

DBMR 연구팀이 사용하는 주요 연구 방법론은 데이터 마이닝, 시장에 대한 데이터 변수의 영향 분석, 주요(산업 전문가) 검증을 포함하는 데이터 삼각 측량입니다. 이 외에도 데이터 모델에는 공급업체 포지셔닝 그리드, 시장 타임라인 분석, 시장 개요 및 가이드, 회사 포지셔닝 그리드, 회사 시장 점유율 분석, 측정 표준, 글로벌 대 지역 및 공급업체 점유율 분석이 포함됩니다. 연구 방법론에 대해 자세히 알아보려면 문의를 남겨 업계 전문가에게 문의하세요  https://www.databridgemarketresearch.com/ko/speak-to-analyst/?dbmr=global-polyclonal-antibodies-market

SKU-52658